Your browser doesn't support javascript.
loading
Retrospective Database Analysis to Explore Patterns and Economic Burden of Switchback to Brand After Generic or Authorized Generic Utilization.
Alderfer, Justine; Aggarwal, Jyoti; Gilchrist, Kim; Alvir, Jose Maria Jimenez; Cook, Joseph; Park, Sang Hee; Stephens, Jennifer M.
Affiliation
  • Alderfer J; Medical Affairs, Pfizer Inc., Collegeville, PA, USA.
  • Aggarwal J; Evidence & Access, OPEN Health, Newton, MA, USA.
  • Gilchrist K; Medical Affairs, Pfizer Inc., Collegeville, PA, USA.
  • Alvir JMJ; Global Product Development, Pfizer Inc., New York, NY, USA.
  • Cook J; Clinical Development and Medical Affairs, Viatris, Canonsburg, PA, USA.
  • Park SH; Evidence & Access, OPEN Health, Bethesda, MD, USA.
  • Stephens JM; Evidence & Access, OPEN Health, Bethesda, MD, USA.
Clinicoecon Outcomes Res ; 14: 281-291, 2022.
Article in En | MEDLINE | ID: mdl-35509961
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation / Risk_factors_studies Language: En Journal: Clinicoecon Outcomes Res Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation / Risk_factors_studies Language: En Journal: Clinicoecon Outcomes Res Year: 2022 Document type: Article Affiliation country: Country of publication: